unknown
Stage
About
Immatics is a biotechnology company developing T-cell receptor (TCR)-based cellular therapies and cancer vaccines that target tumor-specific antigens to treat various cancers.
Explore Immatics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.